BRPI0920629A2 - vacina de combinação com células inteiras de pertússis - Google Patents

vacina de combinação com células inteiras de pertússis

Info

Publication number: BRPI0920629A2
Authority: BR; Brazil
Prior art keywords: pertussis; whole cell; combination vaccine; cell combination; vaccine
Prior art date: 2008-10-24

Application number

BRPI0920629A

Other languages

English (en)

Inventor

Lavit Jambu

Rajesh Jain

Sukhjeet Singh

Original Assignee

Panacea Biotec Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2008-10-24

Filing date

2009-10-23

Publication date

2016-01-12

2009-10-23 Application filed by Panacea Biotec Ltd filed Critical Panacea Biotec Ltd

2016-01-12 Publication of BRPI0920629A2 publication Critical patent/BRPI0920629A2/pt

Links

201000005702 Pertussis Diseases 0.000 title 1
229940001442 combination vaccine Drugs 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0016—Combination vaccines based on diphtheria-tetanus-pertussis
- A61K39/0018—Combination vaccines based on acellular diphtheria-tetanus-pertussis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/099—Bordetella
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/29—Hepatitis virus
- A61K39/292—Serum hepatitis virus, hepatitis B virus, e.g. Australia antigen
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/05—Actinobacteria, e.g. Actinomyces, Streptomyces, Nocardia, Bifidobacterium, Gardnerella, Corynebacterium; Propionibacterium
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/08—Clostridium, e.g. Clostridium tetani
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/095—Neisseria
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/125—Picornaviridae, e.g. calicivirus
- A61K39/13—Poliovirus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/29—Hepatitis virus
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2730/00—Reverse transcribing DNA viruses
- C12N2730/00011—Details
- C12N2730/10011—Hepadnaviridae
- C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
- C12N2730/10134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/32011—Picornaviridae
- C12N2770/32611—Poliovirus
- C12N2770/32634—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Virology (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Immunology (AREA)
Pharmacology & Pharmacy (AREA)
Mycology (AREA)
Microbiology (AREA)
Epidemiology (AREA)
Communicable Diseases (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Oncology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Medicinal Preparation (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

BRPI0920629A 2008-10-24 2009-10-23 vacina de combinação com células inteiras de pertússis BRPI0920629A2 (pt)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
IN2437DE2008		2008-10-24
PCT/IN2009/000599 WO2010046934A1 (en)	2008-10-24	2009-10-23	Combination vaccine with whole cell pertussis

Publications (1)

Publication Number	Publication Date
BRPI0920629A2 true BRPI0920629A2 (pt)	2016-01-12

Family

ID=42119002

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BRPI0920629A BRPI0920629A2 (pt)	2008-10-24	2009-10-23	vacina de combinação com células inteiras de pertússis

Country Status (14)

Country	Link
US (1)	US20110195087A1 (pt)
EP (2)	EP2529750A1 (pt)
JP (1)	JP2012506420A (pt)
CN (1)	CN102196817B (pt)
AP (1)	AP2011005700A0 (pt)
AR (1)	AR073957A1 (pt)
BR (1)	BRPI0920629A2 (pt)
CA (1)	CA2741393A1 (pt)
CL (1)	CL2011000913A1 (pt)
CO (1)	CO6430435A2 (pt)
MA (1)	MA32821B1 (pt)
PE (1)	PE20100365A1 (pt)
RU (2)	RU2504398C2 (pt)
WO (1)	WO2010046934A1 (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN102633898B (zh) *	2012-04-23	2013-11-27	成都欧林生物科技股份有限公司	一种Hib多糖与蛋白结合工艺的优化方法
US9849066B2 (en)	2013-04-24	2017-12-26	Corning Incorporated	Delamination resistant pharmaceutical glass containers containing active pharmaceutical ingredients
CN106075428A (zh) *	2015-07-01	2016-11-09	北京科兴中维生物技术有限公司	一种免疫原性组合物及其制备方法
EA037283B1 (ru) *	2015-09-16	2021-03-04	ЭлДжи КЕМ, ЛТД.	Комбинированная вакцинная композиция для многократного дозирования
UA129115C2 (uk) *	2016-08-26	2025-01-22	Серум Інстітьют Оф Індія Прайвет Лімітед	Комбінована вакцина
KR102657910B1 (ko)	2017-07-18	2024-04-18	세럼 인스티튜트 오브 인디아 프라이비트 리미티드	개선된 안정성, 강화된 면역원성과 감소된 반응원성을 갖는 면역원성 조성물 및 그의 제조 방법
SG11202103622SA (en)	2018-10-12	2021-05-28	Serum Inst Of India Private Ltd	Combination vaccine composition comprising reduced dose inactivated poliovirus and method for preparing the same
WO2020165920A1 (en) *	2019-02-12	2020-08-20	Biological E Limited	Multivalent vaccine composition
WO2021176409A1 (en)	2020-03-05	2021-09-10	Sanofi Healthcare India Private Limited	Preservative combination for vaccine composition

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3097140A (en)	1958-10-31	1963-07-09	Merck & Co Inc	Preparing a mixed polio, pertussis, tetanus, and diphtheria vaccine with benzethonium chloride
US3097142A (en)	1960-03-30	1963-07-09	Merck & Co Inc	Benzyl alcohol stabilized polio vaccines and production thereof
JP3626996B2 (ja) *	1992-05-23	2005-03-09	グラクソスミスクライン・バイオロジカルス・ソシエテ・アノニム	Ｂ型肝炎表面抗原および他の抗原からなる複合ワクチン
US6488934B1 (en) *	1995-02-25	2002-12-03	Smithkline Beecham Biologicals S.A.	Hepatitis B vaccine
FR2734484B1 (fr) *	1995-05-24	1997-06-27	Pasteur Merieux Serums Vacc	Composition vaccinale liquide et procede de fabrication
BR9710460A (pt)	1996-07-02	1999-08-17	Connaught Lab	Composi-Æo imunolÄgica multi-valente e seu uso em vacinas
OA12302A (en)	2000-06-29	2003-10-24	Glaxosmithkline Biolog Sa	Multivalent vaccine composition.
KR100385711B1 (ko)	2000-07-05	2003-05-27	녹십자백신 주식회사	디프테리아, 파상풍 톡소이드와 백일해균 및ｂ형간염표면항원을 포함한 4가 혼합백신 및 그 제조방법
GB0223355D0 (en)	2002-10-08	2002-11-13	Chiron Spa	Vaccine
GB0313916D0 (en)	2003-06-16	2003-07-23	Glaxosmithkline Biolog Sa	Vaccine composition
KR20030069918A (ko)	2003-06-25	2003-08-27	주식회사 삼정산업	간편 조립식 파렛트 판재, 간편 조립식 파렛트 중간지지구및 간편 조립식 파렛트와 그의 제작방법
GB0405787D0 (en)	2004-03-15	2004-04-21	Chiron Srl	Low dose vaccines
MX2007002372A (es) *	2004-08-27	2007-05-08	Panacea Biotec Ltd	Vacuna para la poliomielitis inactivada derivada de la cepa sabin del virus de la polio.
EP2491947A3 (en)	2006-09-07	2012-10-17	GlaxoSmithKline Biologicals S.A.	Vaccine

2009
- 2009-10-22 PE PE2009001195A patent/PE20100365A1/es not_active Application Discontinuation
- 2009-10-23 EP EP11173119.6A patent/EP2529750A1/en not_active Withdrawn
- 2009-10-23 JP JP2011532773A patent/JP2012506420A/ja not_active Withdrawn
- 2009-10-23 RU RU2011120309/15A patent/RU2504398C2/ru active
- 2009-10-23 US US13/125,679 patent/US20110195087A1/en not_active Abandoned
- 2009-10-23 CA CA2741393A patent/CA2741393A1/en not_active Abandoned
- 2009-10-23 BR BRPI0920629A patent/BRPI0920629A2/pt not_active Application Discontinuation
- 2009-10-23 CN CN200980142458.8A patent/CN102196817B/zh active Active
- 2009-10-23 WO PCT/IN2009/000599 patent/WO2010046934A1/en not_active Ceased
- 2009-10-23 EP EP09821705A patent/EP2361094A4/en not_active Withdrawn
- 2009-10-23 AP AP2011005700A patent/AP2011005700A0/xx unknown
- 2009-10-23 AR ARP090104078A patent/AR073957A1/es unknown
2011
- 2011-04-21 CL CL2011000913A patent/CL2011000913A1/es unknown
- 2011-05-20 MA MA33877A patent/MA32821B1/fr unknown
- 2011-05-24 CO CO11063984A patent/CO6430435A2/es not_active Application Discontinuation
- 2011-08-29 RU RU2011135761A patent/RU2613295C2/ru not_active Application Discontinuation

Also Published As

Publication number	Publication date
CO6430435A2 (es)	2012-04-30
RU2504398C2 (ru)	2014-01-20
RU2011135761A (ru)	2013-03-10
MA32821B1 (fr)	2011-11-01
CA2741393A1 (en)	2010-04-29
RU2011120309A (ru)	2012-11-27
WO2010046934A1 (en)	2010-04-29
EP2361094A4 (en)	2012-12-05
US20110195087A1 (en)	2011-08-11
EP2361094A1 (en)	2011-08-31
EP2529750A1 (en)	2012-12-05
CN102196817A (zh)	2011-09-21
RU2613295C2 (ru)	2017-03-15
AP2011005700A0 (en)	2011-06-30
CN102196817B (zh)	2016-04-06
PE20100365A1 (es)	2010-05-21
AR073957A1 (es)	2010-12-15
JP2012506420A (ja)	2012-03-15
CL2011000913A1 (es)	2012-01-20

Legal Events

Date	Code	Title	Description
2016-05-17	B11A	Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
2016-08-09	B11Y	Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]

Publication	Publication Date	Title
BRPI0920630A2 (pt)	2016-01-12	vacina combinada com pertússis acelular
EP2334277A4 (en)	2016-01-06	CRUTCH
DK2344478T3 (da)	2017-11-27	Cc-1065 analoger og deres konjugater
BRPI1016125A2 (pt)	2015-12-22	meio de ancoragem
DK2216140T3 (da)	2013-07-29	Hammer
DK2186966T3 (da)	2014-05-26	Facadekonstruktion
BRPI0914743A2 (pt)	2015-10-20	estrutura
DK2114993T3 (da)	2012-10-22	Vaccine
BRPI0918501A2 (pt)	2015-12-08	bolsa
EP2268582A4 (en)	2012-03-14	SOLARDESTILLATOREN
BRPI0920629A2 (pt)	2016-01-12	vacina de combinação com células inteiras de pertússis
BRPI0913267A2 (pt)	2016-06-14	uso do ácido succínico
BRPI0923550A2 (pt)	2016-01-26	penico
BRPI0910722A2 (pt)	2015-09-29	columbário
DK2379722T3 (da)	2017-01-02	Ekspressionsvektor
FI20085899A0 (fi)	2008-09-23	Puu-Metalli-komposiittirakenne
BRPI0921578A2 (pt)	2019-09-24	vacinas unitemporais
BRPI0909840A2 (pt)	2015-07-28	Uso de 4-tio-2-deoxinucleosídios
HRP20170146T1 (hr)	2017-04-07	Pufa-prekriveni implantati
BRPI0823239A2 (pt)	2015-06-16	Gerador
EP2498815A4 (en)	2014-03-19	VACCINE COMPOSITION
DE112009003312A5 (de)	2013-09-26	Implantat
EP2309854A4 (en)	2012-06-06	ACCELERATED THERAPY:
BRPI0911641A2 (pt)	2018-03-27	unidade estrutural
BRPI0913939A2 (pt)	2016-04-26	dose unitária de apadenoson